Advertisement
Australia markets close in 3 hours 43 minutes
  • ALL ORDS

    7,839.40
    -98.10 (-1.24%)
     
  • ASX 200

    7,577.80
    -105.20 (-1.37%)
     
  • AUD/USD

    0.6531
    +0.0007 (+0.11%)
     
  • OIL

    83.85
    +0.28 (+0.34%)
     
  • GOLD

    2,347.20
    +4.70 (+0.20%)
     
  • Bitcoin AUD

    98,806.24
    +371.20 (+0.38%)
     
  • CMC Crypto 200

    1,392.21
    +9.64 (+0.70%)
     
  • AUD/EUR

    0.6086
    +0.0013 (+0.22%)
     
  • AUD/NZD

    1.0943
    -0.0014 (-0.13%)
     
  • NZX 50

    11,853.12
    -93.31 (-0.78%)
     
  • NASDAQ

    17,430.50
    -96.30 (-0.55%)
     
  • FTSE

    8,078.86
    +38.48 (+0.48%)
     
  • Dow Jones

    38,085.80
    -375.12 (-0.98%)
     
  • DAX

    17,917.28
    -171.42 (-0.95%)
     
  • Hang Seng

    17,586.56
    +302.02 (+1.75%)
     
  • NIKKEI 225

    37,793.23
    +164.75 (+0.44%)
     

Is It Time To Consider Buying ALS Limited (ASX:ALQ)?

While ALS Limited (ASX:ALQ) might not be the most widely known stock at the moment, it saw a double-digit share price rise of over 10% in the past couple of months on the ASX. As a mid-cap stock with high coverage by analysts, you could assume any recent changes in the company’s outlook is already priced into the stock. However, could the stock still be trading at a relatively cheap price? Today I will analyse the most recent data on ALS’s outlook and valuation to see if the opportunity still exists.

Check out our latest analysis for ALS

Is ALS still cheap?

ALS is currently expensive based on my price multiple model, where I look at the company's price-to-earnings ratio in comparison to the industry average. I’ve used the price-to-earnings ratio in this instance because there’s not enough visibility to forecast its cash flows. The stock’s ratio of 34.8x is currently well-above the industry average of 20.65x, meaning that it is trading at a more expensive price relative to its peers. Furthermore, ALS’s share price also seems relatively stable compared to the rest of the market, as indicated by its low beta. If you believe the share price should eventually reach levels around its industry peers, a low beta could suggest it is unlikely to rapidly do so anytime soon, and once it’s there, it may be hard to fall back down into an attractive buying range.

What does the future of ALS look like?

earnings-and-revenue-growth
earnings-and-revenue-growth

Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. With profit expected to grow by 63% over the next couple of years, the future seems bright for ALS. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation.

What this means for you:

Are you a shareholder? ALQ’s optimistic future growth appears to have been factored into the current share price, with shares trading above industry price multiples. However, this brings up another question – is now the right time to sell? If you believe ALQ should trade below its current price, selling high and buying it back up again when its price falls towards the industry PE ratio can be profitable. But before you make this decision, take a look at whether its fundamentals have changed.

ADVERTISEMENT

Are you a potential investor? If you’ve been keeping an eye on ALQ for a while, now may not be the best time to enter into the stock. The price has surpassed its industry peers, which means it is likely that there is no more upside from mispricing. However, the positive outlook is encouraging for ALQ, which means it’s worth diving deeper into other factors in order to take advantage of the next price drop.

So while earnings quality is important, it's equally important to consider the risks facing ALS at this point in time. You'd be interested to know, that we found 1 warning sign for ALS and you'll want to know about it.

If you are no longer interested in ALS, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.